Chinese Court Rules Executives, Auditors Liable for Kangmei Fraud

Kangmei Pharmaceutical, its executives and auditors will be held fully liable for CNY 2.5bn of investor losses in China's first ever class action against corporate fraud.

To continue reading...

Get access today

Sign up for a free 2-week trial and get instant, unrestricted and unlimited access to Regulation Asia.


Already taken your free trial? Get in touch with our team and enquire about a subscription today. Select subscribe below to view our subscription packages or you can email us at [email protected] to discuss your options.


To Top
Share via
Copy link
Powered by Social Snap